Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market, By Method (Direct ELISA, Indirect ELISA, Sandwich ELISA, and Competitive ELISA), Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring and Pharmaceutical Industry and Transplantation, Infectious Diseases, Cancer, Protein Quantitation, Others), Technology (Chemiluminescent, Colorimetric, and Fluorescent), End User (Hospitals and Diagnostic Centers, Research Laboratories) – Industry Trends and Forecast to 2030.
Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Analysis and Size
Cancer occurrence is increasing rapidly, which is anticipated to enhance the demand for effective diagnostic methods such as immunoassay. As per World Health Organization (WHO), around 37.7 million people had HIV in 2020. HIV and AIDS can be well treated with the help of enzyme-linked immunosorbent assay (ELISA) testing. Additionally, widespread research is being carried out for the huge development of technologies and software for enzyme-linked immunosorbent assay (ELISA) testing.
Data Bridge Market Research analyses that the enzyme-linked immunosorbent assay (ELISA) tests market, which was USD 2.35 billion in 2022, would rocket up to USD 4.02 billion by 2030 and is expected to undergo a CAGR of 6.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Method (Direct ELISA, Indirect ELISA, Sandwich ELISA and Competitive ELISA), Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring and Pharmaceutical Industry and Transplantation, Infectious Diseases, Cancer, Protein Quantitation, Others), Technology (Chemiluminescent, Colorimetric, and Fluorescent), End User (Hospitals and Diagnostic Centers, Research Laboratories)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Ortho Clinical Diagnostics (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific (U.S.), Abbott (U.S.), ZEUS Scientific, Inc. (U.S.), B.D. (U.S.), BioMérieux (France), Enzo Life Sciences, Inc.(U.S.), PerkinElmer, Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), BioLegend, Inc (U.S.)., LOEWE Biochemica GmbH (Germany)., ELISA Technologies, Inc (U.S.)., R&D Systems, Inc. (U.S.)., Arbor Assays (U.S.), Eurofins Scientific (Luxembourg), Danaher (U.S.), Sysmex Corporation (Japan), Agilent Technologies, Inc. (U.S.), Bruker (U.S.), Siemens (U.S.), General Electric (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Enzyme-linked immunosorbent assay (ELISA) is a test type performed to identify the presence of antibodies in a liquid biological sample. ELISA is used as a quality control check in numerous industries and as a diagnostic tool in plant pathology and medicine. In numerous sectors, enzyme-linked immunosorbent assay (ELISA) testing is widely used as a quality assurance check and screening tool in medicine and plant pathology.
Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Dynamics
Drivers
- Increasing Initiatives to Raise Awareness
Varied applications of immunoassay-based diagnostics are considerably increasing worldwide. Public awareness campaigns are launched to identify the symptoms of infectious diseases such as HIV and find ways to prevent them. Therefore, growing patient awareness has led to high demand for immunoassays. For instance, the advocacy program by the International Society for Infectious Diseases focused collaborated with public health practitioners, clinicians, and researchers worldwide. It supported the exchange of scientific knowledge and the application of public health practices and evidence-based medicine. Thus, this factor boosts the growth of the market.
- Increasing Demand for Sandwich ELISA
Sandwich ELISA is widely used for detecting immunological response and this factor is supporting the market's growth. Additionally, this type is the most sensitive test, with high flexibility and increased specificity, as numerous antibodies bind to the same antigen for recognition or detection. The major advantage of sandwich ELISA is that the sample is not required to purify before analysis. This saves time for many manufacturers. Thus, this factor boosts market growth.
Opportunities
- Growing Developments by Market Players
There have been increasing developments by key market players, leading to the market's growth. For instance, in 2019, the Native Antigen Company declared the launch of a novel Zika immunoassay known as the NS1 enzyme-linked immunosorbent assay (ELISA) assay, which has significant specificity and sensitivity across a wide range of spectrum of biological samples. Thus, these increasing developments led to the growth of the market.
- Increasing Incidence of Cancer
The growing incidence of cancer cases globally is one of the primary factors leading to the growth of the immunoassay market during the forecast period 2023-2030. As per the report published by the International Agency for Research on Cancer, the occurrence of cancer was projected to be 18.1 million new cases. Around 9.6 million deaths because of the disease were recorded in 2018. Thus, a rise in cancer incidence is anticipated to boost the adoption of immunoassays.
Restraints/Challenges
- High Cost of ELISA Tests
The increased cost of ELISA tests is the major factor impeding market growth. Advanced techniques and expensive culture media are required to process this test. Also, it involves the bulk amount of culture materials as a single mistake can lead to the starting of the test again. Thus, this factor restricts the market growth.
This enzyme-linked immunosorbent assay (ELISA) tests market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the enzyme-linked immunosorbent assay (ELISA) tests market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
• In 2020, Siemens Healthineers announced that its SARS-CoV-2 IgG Antibody Test has proven to evaluate neutralizing antibodies and has gained CE Marking. This test is the better version of its previously launched COVID-19 antibody test
Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Scope
The enzyme-linked immunosorbent assay (ELISA) tests market is segmented on the basis of method, application, technology and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Direct
- Indirect
- Sandwich
- Competitive
Application
- Vaccine Development
- Immunology
- Diagnostics
- Toxicology
- Drug Monitoring and Pharmaceutical Industry and Transplantation
- Infectious Diseases
- Cancer
- Protein Quantitation
- Others
Technology
- Chemiluminescent
- Colorimetric
- Fluorescent
End User
- Hospitals and Diagnostic Centers
- Research Laboratories
Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Regional Analysis/Insights
The enzyme-linked immunosorbent assay (ELISA) tests market is analyzed and market size insights and trends are provided by method, application, technology and end user as referenced above.
The countries covered in the enzyme-linked immunosorbent assay (ELISA) tests market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the enzyme-linked immunosorbent assay (ELISA) tests market due to the well-advanced healthcare infrastructure and the increasing penetration of medical devices. Additionally, increasing expenses on R&D by government organizations and pharmaceutical companies for disorders and diseases such as chronic ailments and diabetes will further enhance the growth of the ELISA tests market in the region during the forecast period.
Asia-Pacific is expected to grow significantly because of the rising disposable income and healthcare expenditure in emerging nations. Additionally, the increase in the adoption of medical devices in advanced countries is further estimated to boost the growth of the ELISA tests market in the upcoming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The enzyme-linked immunosorbent assay (ELISA) tests market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for enzyme-linked immunosorbent assay (ELISA) tests market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the enzyme-linked immunosorbent assay (ELISA) tests market. The data is available for historic period 2011-2021.
Competitive Landscape and Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Share Analysis
The enzyme-linked immunosorbent assay (ELISA) tests market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to enzyme-linked immunosorbent assay (ELISA) tests market.
Some of the major players operating in the enzyme-linked immunosorbent assay (ELISA) tests market are:
- Ortho Clinical Diagnostics (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Thermo Fisher Scientific (U.S.)
- Abbott (U.S.)
- ZEUS Scientific, Inc (U.S.)
- B.D. (U.S.)
- BioMérieux (France)
- Enzo Life Sciences, Inc.(U.S.)
- PerkinElmer, Inc. (U.S.)
- Merck KGaA (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- BioLegend, Inc (U.S.)
- LOEWE Biochemica GmbH (Germany)
- ELISA Technologies, Inc (U.S.).
- R&D Systems, Inc.(U.S.)
- Arbor Assays (U.S.)
- Eurofins Scientific (Luxembourg)
- Danaher (U.S.)
- Sysmex Corporation (Japan)
- Agilent Technologies, Inc. (U.S.)
- Bruker (U.S.)
- Siemens (U.S.)
- General Electric (U.S.)
SKU-